INS and type 2 diabetes mellitus: However, given the very low GIR values during both clamps compared with the GIR typical of middle-age, lean healthy controls receiving the identical insulin infusion [∼6 mg/kg/min, (32, 33)], it was evident that these participants with type 2 diabetes are metabolically insulin resistant both before and after empagliflozin treatment.